Pieris Pharmaceuticals (NASDAQ:PIRS) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Up 2.1 % NASDAQ PIRS opened at $0.20 on Thursday. The stock has a market capitalization of $19.42 million, a P/E ratio […]

Related Keywords

United States ,America , ,Acadian Asset Management ,Pieris Pharmaceuticals Stock ,News Ratings For Pieris Pharmaceuticals Daily ,Silverarc Capital Management ,Blackrock Inc ,America Corp ,Pieris Pharmaceuticals Inc ,Pieris Pharmaceuticals ,Free Report ,Get Free Report ,Asset Management ,Pieris Pharmaceuticals Daily ,Nasdaq Pirs ,Dpirs ,Medical ,Initiated Coverage ,Stocknews Com ,